StockData
Thermo Fisher Scientific Inc. logo

Thermo Fisher Scientific Inc. (TMO) stock

TMONYSEMeasuring & Controlling Devices, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 26, 2026Last filing: 10-Q on Oct 30, 2026Score 10/3028% above fair value
$686.79−4.54 (-0.66%)

Close on Nov 17, 2026Market cap $254.47BP/E 36.2Yield 0.25%

Thermo Fisher Scientific operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Thermo Fisher Scientific's operating cash flow for the twelve months ending Sep 26, 2026 was $9.32B, up 21.9% year over year. For fiscal 2025 it was $7.82B, down 9.8% from the year before. Over ten years it grew 10.3% a year on average. The highest annual figure on record is $9.31B in fiscal 2021.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$7.82B-9.8%
FY2024Dec 31, 2024$8.67B+3.1%
FY2023Dec 31, 2023$8.41B-8.2%
FY2022Dec 31, 2022$9.15B-1.7%
FY2021Dec 31, 2021$9.31B+12.3%
FY2020Dec 31, 2020$8.29B+66.7%
FY2019Dec 31, 2019$4.97B+9.5%
FY2018Dec 31, 2018$4.54B+13.4%
FY2017Dec 31, 2017$4.01B+22.9%
FY2016Dec 31, 2016$3.26B+10.7%
FY2015Dec 31, 2015$2.94B+12.3%
FY2014Dec 31, 2014$2.62B+30.3%
FY2013Dec 31, 2013$2.01B-1.4%
FY2012Dec 31, 2012$2.04B+20.6%
FY2011Dec 31, 2011$1.69B+12.9%
FY2010Dec 31, 2010$1.50B-9.7%
FY2009Dec 31, 2009$1.66B+16.8%
FY2008Dec 31, 2008$1.42B-4.3%
FY2007Dec 31, 2007$1.48B–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 26, 2026$2.55B+13.9%
Q2 FY2026Jun 27, 2026$2.13B+51.9%
Q1 FY2026Mar 28, 2026$1.19B+64.9%
Q4 FY2025Dec 31, 2025$3.46B+5.1%
Q3 FY2025Sep 27, 2025$2.24B+3.4%
Q2 FY2025Jun 28, 2025$1.40B-28.6%
Q1 FY2025Mar 29, 2025$723.00M-42.2%
Q4 FY2024Dec 31, 2024$3.29B-11.6%
Q3 FY2024Sep 28, 2024$2.17B-10.3%
Q2 FY2024Jun 29, 2024$1.96B+27.3%
Q1 FY2024Mar 30, 2024$1.25B+71.6%
Q4 FY2023Dec 31, 2023$3.72B+6.8%
Q3 FY2023Sep 30, 2023$2.41B+24.6%
Q2 FY2023Jul 1, 2023$1.54B+0.8%
Q1 FY2023Apr 1, 2023$729.00M-66.9%
Q4 FY2022Dec 31, 2022$3.49B+41.9%
Q3 FY2022Oct 1, 2022$1.94B-26.9%
Q2 FY2022Jul 2, 2022$1.53B-31.4%
Q1 FY2022Apr 2, 2022$2.20B+11.3%
Q4 FY2021Dec 31, 2021$2.46B-26.4%
Q3 FY2021Oct 2, 2021$2.65B-2.1%
Q2 FY2021Jul 3, 2021$2.23B+18.1%
Q1 FY2021Apr 3, 2021$1.98B+455.6%
Q4 FY2020Dec 31, 2020$3.34B+74.5%
Q3 FY2020Sep 26, 2020$2.71B+142.4%
Q2 FY2020Jun 27, 2020$1.89B+45.7%
Q1 FY2020Mar 28, 2020$356.00M-45.1%
Q4 FY2019Dec 31, 2019$1.91B+6.2%
Q3 FY2019Sep 28, 2019$1.12B-8.4%
Q2 FY2019Jun 29, 2019$1.29B-10.4%
Q1 FY2019Mar 30, 2019$649.00M+732.1%
Q4 FY2018Dec 31, 2018$1.80B-3.5%
Q3 FY2018Sep 29, 2018$1.22B+31.3%
Q2 FY2018Jun 30, 2018$1.44B+70.1%
Q1 FY2018Mar 31, 2018$78.00M-78.4%
Q4 FY2017Dec 31, 2017$1.87B+54.8%
Q3 FY2017Sep 30, 2017$929.00M–
Q2 FY2017Jul 1, 2017$849.00M–
Q1 FY2017Apr 1, 2017$361.00M–
Q4 FY2016Dec 31, 2016$1.21B–

More Thermo Fisher Scientific figures

See a number that looks wrong?